Capping Prescription Costs Act of 2025

Bill 119 s 529, also known as the Prescription Drug Cost Sharing Limitation Act, aims to address the rising costs of prescription drugs by placing limits on the amount that individuals are required to pay out of pocket for their medications. The bill seeks to make prescription drugs more affordable for all Americans, regardless of their income or insurance coverage.

Under this legislation, insurance companies would be prohibited from charging excessive cost-sharing amounts for prescription drugs. This means that individuals would not have to pay more than a certain percentage of the total cost of their medications, making it easier for them to access the treatments they need without facing financial hardship.

In addition to limiting cost-sharing, the bill also includes provisions to increase transparency in drug pricing and promote competition in the pharmaceutical industry. By making it easier for consumers to compare prices and access lower-cost alternatives, the legislation aims to drive down overall prescription drug costs and improve access to affordable medications for all Americans. Overall, Bill 119 s 529 represents a bipartisan effort to address the growing issue of high prescription drug costs in the United States. By placing limits on cost-sharing, increasing transparency, and promoting competition, the legislation aims to make prescription drugs more affordable and accessible for all Americans.